| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453527A2 Method for obtaining oestrogen from mare urine |
| 09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 09/08/2004 | EP1453521A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 09/08/2004 | EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/08/2004 | EP1453500A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1383512B1 Use of sucralfate for the treatment of cervical erosion |
| 09/08/2004 | EP1235850B1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1526721A Extraction process of conjugated female hormone |
| 09/08/2004 | CN1526446A Recombinant phage vaccine of tumor proliferation related growth factor and its application |
| 09/08/2004 | CN1526439A Chinese medicine for treating women's sterility and its prepn and use |
| 09/08/2004 | CN1526386A Houttuynin sodium powder injection and its prepn |
| 09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165342C Porcine reproductive and respiratory syndrome vaccine |
| 09/08/2004 | CN1165341C Liquid gonadotropin containing formulations |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165321C Recipe and prepn process of spleen and kidney invigorating medicine |
| 09/08/2004 | CN1165320C Externally applied medicine for treating cervical erosion and its prepn |
| 09/08/2004 | CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787548 Cardiovascular insufficiency and erectile dysfunction; 3-(4-(3-chloro-4-hydroxybenzylamino) benzo(4,5)thieno(2,3-d)pyrimidin-2-yl)propionic acid |
| 09/07/2004 | US6787342 Paste formulations |
| 09/07/2004 | US6787134 Methods for preventing/remedying mastitis |
| 09/07/2004 | CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| 09/02/2004 | WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above |
| 09/02/2004 | WO2004073586A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | US20040171832 Novel sulfonate substituted pyrazol pyridine derivatives |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171690 Use of protein essential aminoacids to treat amenorrhea and related disorders |
| 09/02/2004 | US20040171685 Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia |
| 09/02/2004 | US20040171660 Single dose aromatase inhibitor for treating infertility |
| 09/02/2004 | US20040171605 Benzoxazepines derivatives and their use as ampa receptor stimulators |
| 09/02/2004 | US20040171530 Polypeptides containing cysteine and tryptophan |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170713 To promote good health and as a dietary additive |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | US20040170573 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 09/02/2004 | US20040170569 Dosage forms that rapidly produces peak plasma concentrations; heating a thin layer of the drug on a solid support to form a vapor; and passing air through the heated vapor to produce aerosol particles having less than 10% drug degradation products |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
| 09/01/2004 | EP1451166A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1450849A2 Methods of treating endometreosis |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 09/01/2004 | EP1450821A1 Immunostimulatory oligodeoxynucleotides |
| 09/01/2004 | EP1450813A1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | EP1450786A1 Isoflavone concentrate and method for production thereof |
| 09/01/2004 | EP1450782A1 Use of alkanoyl l-carnitine for the treatment of erectile dysfunction |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450772A1 Micronized film-forming powder comprising an active substance |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1347977B1 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones |
| 09/01/2004 | EP1194138A4 Nutritional supplements |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1524577A Alkaline fibroblast growth factor pellicle and its production method |
| 09/01/2004 | CN1524559A Capsule for curing colpitis |
| 09/01/2004 | CN1524541A Traditional Chinese medicinal suppository for treating stagnancy of qi and blood stasis for women |
| 09/01/2004 | CN1164603C 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 09/01/2004 | CN1164318C Capsule for treating gynaecological inflammation |
| 09/01/2004 | CN1164317C Revival pill for treating woman diseases |
| 09/01/2004 | CN1164313C Chinese medicine for treating women's menalgia, pelvic infection and vaginitis |